Abbvie Stock News

First National Bank of Mount Dora Trust Investment Services lessened its stake in AbbVie Inc. (NYSE:ABBV) by 1.7% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 39,993 shares of the company’s stock after selling 708 shares during the quarter. First National Bank […]

The global TNF inhibitors market was valued around US$ 40,369.8 Mn in 2017. It is anticipated to expand at a stable CAGR of 2.54% during the forecast period of 2018 to 2026, according to a new report published by Transparency

Canandaigua National Corp increased its holdings in AbbVie Inc. (NYSE:ABBV) by 8.2% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 32,011 shares of the companys stock after purchasing an additional 2,435 shares during the quarter. Canandaigua National Corps holdings in AbbVie []

Complete study of the global Growth Hormone Deficiency Therapy market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding

Complete study of the global JAK and PI3K Signaling Pathway market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear

The HER2 Inhibitors report published by Data Bridge Market research is the representation of data and analysis of the market. It gives detailed analysis of the current market scenario and a market forecast till 2028. The data included

Birch Capital Management LLC trimmed its stake in AbbVie Inc. (NYSE:ABBV) by 3.2% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 13,692 shares of the companys stock after selling 447 shares during the period. AbbVie makes up about 1.0% of Birch Capital Management LLCs investment portfolio, making the stock its 29th biggest []

Maverick Capital Ltd. purchased a new stake in shares of AbbVie Inc. (NYSE:ABBV) in the 2nd quarter, Holdings Channel reports. The fund purchased 14,279 shares of the companys stock, valued at approximately $1,608,000. A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Nations Financial Group Inc. []